Y52: Agents primarily affecting the cardiovascular system
Y52.0: Cardiac-stimulant glycosides and drugs of similar action
Cardiac-stimulant glycosides and drugs of similar action are substances that influence the function of the heart and the cardiovascular system. Often used in the treatment of cardiac disorders, these drugs work by increasing the force of the heart's contraction and slowing the rate of the heart's beat, improving blood flow and reducing symptoms like shortness of breath and fatigue associated with heart conditions. However, adverse reactions to these medications can occur which include nausea, loss of appetite, confusion, vision changes, and irregular heart rhythms. In particular, arrhythmias (abnormal heart rhythms) pose a considerable risk since they can lead to more serious heart conditions or even cardiac arrest. It is important to monitor the intake of these drugs consistently to manage these potential reactions.
Patient Disclaimer
The information provided on this page is for general educational purposes only. It is not intended for self-diagnosis and does not replace professional medical advice. Always consult your doctor or a qualified healthcare provider with any questions or concerns about your health.
If you see an ICD diagnosis code (e.g., on a medical report), be aware that doctors may also include additional indicators to express diagnostic certainty. Only a healthcare professional can interpret these codes accurately in the context of your individual case.
For a complete understanding of your condition and what the diagnosis means for you, please speak directly with your doctor.